The DETECT HCV Screening Trial
Key facts
- Who runs it
- Denver Health and Hospital Authority
- Where
- Baltimore, Denver, and Jackson, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 147,533 people enrolled
- Started
- 20 Nov 2019
- Ended
- 31 Jan 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- HCV Screening
- Record updated
- 6 February 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Present to EDs during study enrollment period
- Clinically stable per screening nurse or physician assessment
- Able to provide consent for medical care
Who cannot take part
- Are unable to consent for care (i.e., altered mentation, critical illness, or injury)
- Self-Identify as already living with HCV
- Younger than 18 years of age
- Have already participated in the trial
Where in United States
- Johns Hopkins UniversityBaltimore, United States
- Denver Health Medical CenterDenver, United States
- University of Mississippi Medical CenterJackson, United States
About the trial
What the trial wants to find out
The investigators propose to compare the effectiveness of nontargeted rapid opt-out hepatitis C (HCV) screening versus targeted rapid opt-out HCV screening using recommended risk characteristics in multiple urban emergency departments (EDs) across the United States (Aim 1 - "Screening Trial").
The 2 groups in the trial
- Nontargeted ScreeningOther group
The nontargeted HCV screening arm will consist of implementing non-risk-based rapid opt-out HCV screening.
Treatment: HCV Screening
- Targeted ScreeningOther group
The targeted HCV screening arm will consist of implementation of risk-based rapid opt-out HCV screening using current recommendations for HCV screening by the CDC, USPSTF, and AASLD-IDSA. Targeted HCV screening will consist of offering HCV testing to those identified with the following specific risk characteristics, adapted from the above recommendations: born between 1945 - 1965 ("birth cohort"); injection drug use (IDU); intranasal drug use;tattoo or piercing in an unregulated setting; or blood transfusion or organ recipient before 1992.
Treatment: HCV Screening
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
- Publications
- Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial.JAMA, 2025
- The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments.Trials, 2022
- Record updated
- 6 February 2025